help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 20, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0071
A more recent version of this article appeared on June 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/6/2363    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by März, W.
Right arrow Articles by Hoffmann, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by März, W.
Right arrow Articles by Hoffmann, M. M.

Submitted on January 12, 2006
Accepted on March 12, 2007

Alanine to serine polymorphism at position 986 of the calcium-sensing receptor associated with coronary heart disease, myocardial infarction, all-cause and cardiovascular mortality

Winfried März MD*, Ursula Seelhorst MA, Britta Wellnitz LLD, Beate Tiran MD, Barbara Obermayer-Pietsch MD, Wilfried Renner PhD, Bernhard O. Boehm MD, Eberhard Ritz MD, and Michael M. Hoffmann PhD

Synlab Centre of Laboratory Diagnostics (W.M.), Heidelberg, Germany; the LURIC Study nonprofit LLC (U.S., B.W.), Freiburg, Germany; the Clinical Institute of Medical and Chemical Laboratory Diagnostics (B.T., W.R.) and the Division of Endocrinology, Department of Medicine (B.O.P.), Medical University of Graz, Austria; the Division of Endocrinology and Diabetes, Department of Medicine (B.O.B.), University Hospital, Ulm, Germany; the Department of Medicine (E.R.), University of Heidelberg, Germany; and the Division of Clinical Chemistry, Department of Medicine (M.M.H.), University of Freiburg, Germany

* To whom correspondence should be addressed. E-mail: maerz{at}synlab.de.

Background - Disorders of calcium homeostasis have been implicated in atherosclerosis. The calcium-sensing receptor (CASR) is crucial to the regulation of calcium metabolism. An alanine (A) to serine (S) polymorphism at codon 986 (A986S) of the CASR gene has been associated with higher calcium and osteoporosis; the association with coronary artery disease (CAD) has not been studied.

Methods and Results - We investigated this polymorphism in individuals with CAD (n=2561) including survivors of myocardial infarction (MI, n=1358) compared to 698 controls without angiographic CAD. Compared to AA homozygotes, the prevalence of CAD (multivariate OR 1.25; 95% CI: 1.02-1.54) and previous MI (multivariate OR 1.33; 95% CI: 1.06-1.68) was increased in carriers of at least one S-allele. With each S-allele the prevalence of CAD and MI increased 1.22-fold (95% CI: 1.02-1.47) and 1.30-fold (95% CI: 1.06-1.60), respectively. Fully adjusted hazard ratios for total and cardiovascular mortality per one S-allele were 1.24 (95% CI: 1.05-1.46) and 1.38 (95% CI: 1.13-1.67), respectively. In carriers of at least one S-allele the adjusted hazard ratios for all-cause and cardiovascular death were 1.25 (95% CI: 1.04-1.51), and 1.48 (95% CI: 1.18-1.86), respectively. These associations were independent of cardiovascular risk factors, calcium and phosphate. The S-allele was associated with higher calcium (P<0.001) and parathyroid hormone (P<0.02), and lower phosphate (P<0.003) in CAD patients and controls.

Conclusion - Serine at position 986 of CASR may be an independent genetic predictor of angiographic CAD, previous MI and cardiovascular mortality.

CONDENSED ABSTRACT

We examined an alanine to serine polymorphism at codon 986 of the calcium-sensing receptor (CASR) in relation to coronary artery disease (CAD), myocardial infarction (MI) and mortality from all causes. Serine at position 986 was associated with higher calcium and parathyroid hormone, and lower phosphate concentrations. Serine at position 986 also increased the risk of CAD, MI, total and cardiovascular mortality, independent of conventional risk factors and serum calcium or phosphate.


Key words: coronary artery disease • myocardial infarction • calcium-sensing receptor • genetics







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society